Clinical Trial Update: Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus

View source ↗

Summary

A clinical trial update indicates that the linagliptin study in Filipino patients with Type 2 diabetes mellitus was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: TERMINATED | Results posted: 2014-09-18